Platelet-Rich Plasma vs. Novel Cross-linked Hyaluronic Acid Injection for Early Knee Osteoarthritis
How to Cite
OrthoEvidence. Platelet-Rich Plasma vs. Novel Cross-linked Hyaluronic Acid Injection for Early Knee Osteoarthritis. ACE Report. 2022;294(1):6. Available from: https://myorthoevidence.com/AceReport/Report/14991
Comparing the Efficacy of Intra-Articular Single Platelet-Rich Plasma(PRP) versus Novel Crosslinked Hyaluronic Acid for Early-Stage Knee Osteoarthritis: A Prospective, Double-Blind, Randomized Controlled TrialMedicina (Kaunas). 2022 Aug 1;58(8): 1028.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
116 patients with early-stage knee osteoarthritis were randomized to receive a single intra-articular injection of a novel cross-linked hyaluronic acid (HA; n=58) or platelet-rich plasma (PRP; n=58). The outcome of interest was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and associated sub-scores, measured at 1, 3 and 6 months follow-up. Results revealed similar scor...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE